| BCICX | FCANX | BCICX / FCANX | |
| Total Expense Ratio | 1.57 | 1.52 | 103% |
| Annual Report Gross Expense Ratio | 1.69 | 1.55 | 109% |
| Fund Existence | 18 years | 19 years | - |
| Gain YTD | 3.324 | 5.563 | 60% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | 100 | 500 | 20% |
| Net Assets | 10.5B | 2.27B | 462% |
| Annual Yield % from dividends | 4.93 | 1.83 | 270% |
| Returns for 1 year | 9.15 | 12.79 | 72% |
| Returns for 3 years | 14.33 | 21.34 | 67% |
| Returns for 5 years | 16.96 | 15.03 | 113% |
| Returns for 10 years | 54.08 | 42.82 | 126% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ILCG | 117.14 | 2.24 | +1.95% |
| iShares Morningstar Growth ETF | |||
| DUNK | 24.48 | 0.31 | +1.28% |
| Dana Unconstrained Equity ETF | |||
| AIVL | 128.88 | 1.05 | +0.82% |
| WisdomTree US Al Enhanced Val ETF | |||
| ZOCT | 27.59 | 0.04 | +0.15% |
| Innovator Eq Dfnd Prt ETF - 1 Yr Oct | |||
| BIB | 85.02 | 0.07 | +0.08% |
| ProShares Ultra Nasdaq Biotechnology | |||